Skip to main content
Equibles

Raymond J. Tesi

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Raymond J. Tesi

Raymond J. Tesi was last confirmed as CEO and Board Member at Inmune Bio, Inc. (INMB) in a filing dated April 21, 2025. The proxy statement of Inmune Bio, Inc. reports total compensation of $2,849,504 for Raymond J. Tesi in fiscal 2025, including a base salary of $486,108. Disclosed compensation is on record for 6 fiscal years. Raymond J. Tesi has spoken on 2 earnings calls across 1 company, most recently for Inmune Bio, Inc. on November 1, 2024.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Inmune Bio, Inc. (INMB)

    Board Member

    Proxy statement

    2015-01-01–2025-04-21

    Last confirmed by a filing; no departure on record

  • Inmune Bio, Inc. (INMB)

    CEO

    Proxy statement

    Start not stated–2025-04-21

    Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Inmune Bio, Inc. (INMB) $486,108 $2,849,504
2024 Inmune Bio, Inc. (INMB) $513,639 $3,008,174
2023 Inmune Bio, Inc. (INMB) $500,500 $1,694,818
2022 Inmune Bio, Inc. (INMB) $455,000 $1,444,509
2021 Inmune Bio, Inc. (INMB) $455,000 $2,702,228
2020 Inmune Bio, Inc. (INMB) $300,000 $300,000

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.